Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

An algorithm for classifying tumors based on genomic aberrations and selecting representative tumor models

BMC Medical Genomics20103:23

DOI: 10.1186/1755-8794-3-23

Received: 27 January 2010

Accepted: 22 June 2010

Published: 22 June 2010

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
27 Jan 2010 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
12 Feb 2010 Author responded Author comments - Xin Lu
Resubmission - Version 3
12 Feb 2010 Submitted Manuscript version 3
2 Mar 2010 Reviewed Reviewer Report - Ping Ma
3 Mar 2010 Reviewed Reviewer Report - Jaakko Hollmén
4 Mar 2010 Reviewed Reviewer Report - Osamu Gotoh
15 Apr 2010 Author responded Author comments - Xin Lu
Resubmission - Version 4
15 Apr 2010 Submitted Manuscript version 4
12 May 2010 Reviewed Reviewer Report - Osamu Gotoh
30 May 2010 Reviewed Reviewer Report - Jaakko Hollmén
15 Jun 2010 Author responded Author comments - Xin Lu
Resubmission - Version 5
15 Jun 2010 Submitted Manuscript version 5
Publishing
22 Jun 2010 Editorially accepted
22 Jun 2010 Article published 10.1186/1755-8794-3-23

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Global Pharmaceutical Research and Development, Abbott Laboratories
(2)
Department of Pathology, School of Medicine & Health Sciences, University of North Dakota
(3)
Astellas Pharma Global Development, INC.
(4)
Department of Pathology, Rush University Medical Center

Advertisement